Derivative Instruments And Hedging Activities (Tables)

9 Months Ended

Nov. 30, 2011

Designated As Hedging Instrument [Member]

Derivatives, Fair Value [Line Items]


	Nine Months Ended November 30, 2011

				Initial Notional
	Number of			Amount
Product	Instruments	Initial Term		(in thousands)
Interest rate swaps	16	46 months	$	1,935,000

As of November 30, 2011, we had the following outstanding derivatives that were designated as cash flow hedges:


	As of November 30, 2011
				Current
				Notional
	Number of			Amount
Product	Instruments	Remaining Term		(in thousands)
Interest rate swaps	10	46 months	$	957,000

Schedule Of Fair Values Of Derivative Instruments On The Consolidated Balance Sheets



			As of November 30						As of February 28
(In thousands)	Location		2011			2010			2011			2010
Asset derivatives:
Interest rate swaps	Other current assets	$	530		$	0		$	2,105		$	0
Interest rate swaps	Accounts payable		0			603			0			0
Liability derivatives:
Interest rate swaps	Accounts payable		(469	)		(274	)		(1,093	)		0
Total		$	61		$	329		$	1,012		$	0

Schedule Of Effect Of Derivative Instruments On The Consolidated Statements Of Earnings



		Three Months Ended				Nine Months Ended
		November 30				November 30
(In thousands)		2011		2010		2011		2010
Interest rate swaps:
Loss recognized in AOCL ⁽¹⁾	$	1,244	$	2,571	$	18,362	$	11,059
Loss reclassified from AOCL into CAF Income ⁽¹⁾	$	2,258	$	750	$	4,353	$	1,049
Loss recognized in CAF Income ⁽²⁾	$	0	$	0	$	0	$	4

⁽¹⁾Represents the effective portion.

⁽²⁾Represents the ineffective portion and amount excluded from effectiveness testing.

Not Designated As Hedging Instrument [Member]

Derivatives, Fair Value [Line Items]

Schedule Of Interest Rate Derivatives


	Nine Months Ended November 30, 2011
				Initial
				Notional
	Number of			Amount
Product	Instruments	Initial Term		(in thousands)
Interest rate caps ⁽¹⁾	2	53 months	$	0

⁽¹⁾Includes one asset derivative and one liability derivative with offsetting initial notional amounts of $20.1 million.

As of November 30, 2011, we had the following outstanding derivatives that were not designated as accounting hedges:


	As of November 30, 2011
				Current
				Notional
	Number of			Amount
Product	Instruments	Remaining Term		(in thousands)
Interest rate swaps	4	14 to 21 months	$	87,801
Interest rate caps ⁽¹⁾	12	21 to 50 months	$	0

⁽¹⁾Includes six asset derivatives and six liability derivatives with offsetting notional amounts of $887.9 million.

Schedule Of Fair Values Of Derivative Instruments On The Consolidated Balance Sheets



			As of November 30						As of February 28
(In thousands)	Location		2011			2010			2011			2010
Asset derivatives:
Interest rate swaps	Other current assets	$	526		$	1,267		$	1,136		$	1,279
Interest rate caps	Other current assets		304			700			778			1,999
Liability derivatives:
Interest rate swaps	Accounts payable		(699	)		(3,595	)		(2,742	)		(7,171	)
Interest rate caps	Other current assets		(303	)		(700	)		(779	)		(1,982	)
Total		$	(172	)	$	(2,328	)	$	(1,607	)	$	(5,875	)

Schedule Of Effect Of Derivative Instruments On The Consolidated Statements Of Earnings



			Three Months Ended						Nine Months Ended
			November 30						November 30
(In thousands)	Location		2011			2010			2011			2010
Gain on interest rate swaps	CAF Income	$	291		$	1,621		$	1,387		$	2,941
Net periodic settlements and accrued
interest	CAF Income		(299	)		(1,658	)		(1,470	)		(7,120	)
Total		$	(8	)	$	(37	)	$	(83	)	$	(4,179	)

- Definition

Tabular disclosure of the location and amount of gains and losses reported in the statement of financial performance, or when applicable, the statement of financial position. For example, (a) gains and losses recognized in the income statement on derivative instruments designated and qualifying as hedging instruments in fair value hedges and related hedged items designated and qualifying in fair value hedges and (b) gains and losses initially recognized in other comprehensive income on derivative instruments designated and qualifying as cash flow hedges.

+ References+ Details

- Definition

Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.

+ References+ Details